{
    "medicine_id": "80b7a8495c2766c6d7414e6115d86669327aeb99",
    "platform_id": "DB15660",
    "metadata": {
        "name": "CMC Pain Relieving Ointment",
        "composition": "N4 Hydroxycytidine",
        "clinical_particulars": {
            "therapeutic_indications": "N4 hydroxycytidine and its prodrug EIDD 2801 is being studied for its activity against a number of viral infections including influenza MERS CoV and SARS CoV 2 A193014 A193029",
            "contraindications": {
                "disease": "Data regarding overdose of N4 hydroxycytidine is not readily available The therapeutic index of N4 hydroxycytidine against a clinical isolate of SARS CoV 2 is expected to be 100 with an _in vitro_ IC sub 50 sub of 0 3\u00b5M and a CC sub 50 sub of 10\u00b5M A193014",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}